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Human immunodeﬁciency virus (HIV-1) depends upon host-encoded proteins to facilitate its replica-
tion while at the same time inhibiting critical components of innate and/or intrinsic immune response
pathways. To characterize the host cell response on protein levels in CD4þ lymphoblastoid SUP-T1
cells after infection with HIV-1 strain LAI, we used mass spectrometry (MS)-based global quantitation
with iTRAQ (isobaric tag for relative and absolute quantiﬁcation). We found 266, 60 and 22 proteins
differentially expressed (DE) (P-valuer0.05) at 4, 8, and 20 hours post-infection (hpi), respectively,
compared to time-matched mock-infected samples. The majority of changes in protein abundance
occurred at an early stage of infection well before the de novo production of viral proteins. Functional
analyses of these DE proteins showed enrichment in several biological pathways including protein
synthesis, cell proliferation, and T-cell activation. Importantly, these early changes before the time of
robust viral production have not been described before.
Published by Elsevier Inc.Introduction
During the 30-year history of Acquired Immunodeﬁciency
Syndrome (AIDS), more than 60 million people have been infected
with its causative agent, HIV-1, and more than 25 million people
have died (UNAIDS, 2009). While treatment options exist for
AIDS, it still remains a signiﬁcant challenge worldwide with an
estimated 2.6 million people newly infected every year and
1.8 million people succumbing to the disease (UNAIDS, 2009).
Therefore, research in HIV biology is of critical importance for
development of new antiviral treatment modalities.
Among the hallmarks of HIV-1 infection is disruption of the
adaptive immune system caused by gradual depletion of CD4þ
T cells (Gruters et al., 1990) leading to a slow decline in immune
functions, with eventual failure to control normally tolerated
pathogens. Like all viruses, HIV-1 depends upon the host cellular
machinery for its survival and replication, orchestrated byInc.
ology, University of
0, USA. Fax: þ206 732 6056.complex interactions between host and viral biomolecules
(Bushman et al., 2009; Jager et al., 2012; MacPherson et al.,
2010; Pinney et al., 2009). These interactions modulate host cell
processes to facilitate expression of viral structural proteins,
assembly of progeny virions and their release. Moreover, the
virus has evolved ways to inhibit the antiviral host cell response
by interacting with critical components of innate and/or intrinsic
immune response pathways (Malim and Emerman, 2008). While
the transcriptional processes affected by viral infection have been
extensively studied, the knowledge of protein level changes is
relatively limited. Recent advances in more sensitive and high
throughput mass spectrometry(MS)-based methods, and bioinfor-
matics tools has allowed studying the complex and dynamic
range of the cellular proteome (Aebersold and Mann, 2003;
Borchers and Tomer, 1999; Han, Aslanian, and Yates, 2008;
Melendez et al., 2011). Quantitative MS-based approaches have
been recently implemented to study changes in host protein
abundance in T-cells upon HIV-infection (Chan et al., 2007;
Chan et al., 2009; Ringrose et al., 2008) or in the presence of viral
protein expressed from a plasmid (Coiras et al., 2006). These
previous studies showed that the majority of host protein
abundance changes occurred at the time when intracellular viral
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proteins have been shown to change early after HIV infection. It is
possible that potentially important but subtle changes in protein
levels as early as 4 hpi were not measurable due to lower
speciﬁcity, sensitivity, and accuracy of the previously used ﬂuor-
escence two-dimensional differential in-gel electrophoresis
(2D-DIGE) (Ringrose et al., 2008) and proteolytic 18O labeling
quantitation methods (Chan et al., 2007).
Our study is an effort to ﬁll this gap in knowledge of very early
changes in host proteins after HIV infection. We used the isobaric
tag for relative and absolute quantitation (iTRAQ) method suitable
for comparative analysis of complex sample mixtures with high
precision (Ross et al., 2004; Wolf-Yadlin et al., 2007; Wu et al., 2006)
to measure global protein abundance in the CD4þ T cell line SUP-
T1, at 4, 8, and 20 hours post infection (hpi) with HIV-1 (strain LAI).
Our new data revealed temporal changes in host proteome, most
prominently in the ribosomal proteins and translational machinery
starting as early as 4 hpi, suggesting that HIV might disrupt cellular
functions of the infected T-cell even before the time of peak
intracellular viral protein and virion production.Fig. 2. (a) Real time PCR was used to determine relative viral RNA copy number
(y-axis) in supernatants of infected SUP-T1 cells at different times post infection
(x-axis). (b) Abundance change of HIV protein Gag over the course of infection, as
determined by iTRAQ quantitation. The fold change ratio of the Gag protein
(y-axis) is expressed relative to the intensity of the corresponding iTRAQ reporter
ion for the mock-infected sample at 4, 8 and 20 hpi (x-axis). There is no detectable
Gag protein in mock-infected samples and the ratio represents the fold-change
over the background intensity. The error bars represent the standard deviation
between three independent biological replicates.Results and discussion
Here we describe changes in the global proteome of the T
lymphocyte cell line CD4þ SUP-T1 during the course of HIV-1
infection. We used an MOI of 2.5, which resulted in close to 100%
infection rate and collected samples in triplicate at 4, 8 and 20 hpi
for both infected and time-matched mock infection. De novo viral
RNA expression in this system was not detected by real-time PCR
until 12 hpi, after which there was a rapid increase in expression
between 12 and 24 hpi (Fig. 2a). This trend closely matched the
detection of the HIV Gag protein (Fig. 2b). Gag was only detected
at close to background levels at 4 and 8 hpi, followed by a
signiﬁcant increase by 20 hpi. Therefore, we established that the
early 4 and 8 hpi time points are associated with minimal de novo
production of viral proteins.
Distribution of subcellular locations and functions of the detected
T-cell proteome
We detected 2847 proteins, which are distributed among
main subcellular compartments as shown in Suppl. Fig. S4.
Public annotations indicate that 51% of the detected proteins areFig. 1. iTRAQ sample preparation scheme. Samples, including the pools from each
single biological replicate were labeled using iTRAQ labels 113–119. Labeled
samples were mixed prior fractionation using Strong Cation Exchange (SCX) resin.nuclear, while cytosolic proteins accounted only for 5% of the
total detected proteome. The remaining 45% of proteins were the
constituents of mitochondrion, cytoskeleton, and plasma mem-
brane. Such overrepresentation of nuclear proteins is expected for
lymphocytes such as SUP-T1 that have small amounts of cytosol.
Out of all detected peptides 22% corresponded to the highly
abundant ribosomal and other cellular housekeeping proteins (5%
and 17%, respectively), while the remaining 78% corresponded to
proteins of relatively lower abundance. The ability to detect the
latter proteins was due to the sample fractionation steps prior
the MS analysis steps (see Methods), as well as the result of fast
scan rate (1 Hz) of the mass spectrometer, which increased the
chance of low abundant peptide ions to get identiﬁed in the
presence of the peptide ions of highly abundant proteins.
Temporal quantitative changes in host proteome after HIV infection
We have conﬁdently quantiﬁed by MS-based iTRAQ analysis
1448 out of 2847 detected cellular proteins (with 2 or more
unique peptides). A t-test on protein level (see Methods) was
performed for each time point individually to derive proteins
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SupT1 cells (results are shown in Table 1). We further ﬁltered
statistically signiﬁcant proteins with the adjusted P-valueo0.05
by selecting a fold-change (FC) cutoff of 71.4 (infected/mock).
This FC cutoff was selected based on the estimation of variation in
protein abundance ratios in mock-infected samples at 4 and 8 hpi
based on the assumption that no biologically signiﬁcant changes
are expected for the mock samples within this 4 h window (Fig. 3).
As shown in the histogram in Fig. 3, 7.4% of such ratios showed FC
of 1.4 or more and 2.6% of ratio showed FC of 1.4 or less. Therefore,
an overall expectation of ﬁnding fold changes 71.4 due to
technical variation between cell culture replicates is 10%. We
used this FC cutoff and applied a t-test ﬁlter (Pr0.05, B–H
adjusted) to derive 348 statistically signiﬁcant proteins, which
showed differential abundance in at least one time point (Table 1).
Surprisingly, most of the detected DE proteins (266/348) exhibited
changes at 4 hpi as compared to the 60 DE proteins at 8 hpi, and
22 DE proteins at 20 hpi. It is unlikely that the low number of
statistically signiﬁcant proteins observed 20 hpi is due to higher
variability between triplicates or in the ratios for that time point
as the histogram of all observed protein ratios does not reﬂect an
increase in variability (Suppl. Fig. S3). The overlap of the 348 DEFig. 3. (a) Histogram of number of identiﬁed proteins and their log2 intensity ratio
at 4 hpi/8 hpi. The histogram was used to determine the number of DE proteins
passing fold change thresholds of 1.2, 1.4, and 2.0 by random chance. (b) Table of
estimated probabilities of a DE protein at different FC thresholds.
Table 1
Differentially expressed (DE) cellular proteins in HIV-infected CD4þ SUP-T1 cells.
No. of DEa proteins at
4 hpi 8 hpi 20 hpi
Up-regulated proteins
FCbZ1.4 117 26 4
FCZ2 18 2 0
Down-regulated proteins
FCZ1.4 149 34 18
FCZ2 55 7 7
a Differentially expressed (DE) proteins are the proteins that showed abun-
dances changes in the HIV-infected cells as compared to their time-matched
mocks with a nominal (P-valueo0.05).
b FC, fold change.proteins (Pr0.05, FCZ1.4) at the three time points is shown in
the Venn diagram in Fig. 4a. Only 25 DE proteins are shared
between the early time points (4 and 8 hpi), while only one
protein (UTP14A, U3 small nucleolar RNA-associated protein 14)
overlapped between 8 and 20 hpi DE lists. The small overlap
between the early time points vs. the late time point suggests that
completely different sets of host proteins or processes were
perturbed in these times.
A global view of the protein abundance changes of the 348 DE
proteins is shown in Fig. 4b. The directionality of abundance
changes for 22 of the 25 overlapping DE proteins between 4 and
8 hpi remained consistent at these time points (4b). It is note-
worthy that we observed down regulation of HIV-1 dependency
factor Tat speciﬁc factor 1 (HTATSF1) implicated by some inves-
tigators in regulation of Tat transactivation in viral RNA transcrip-
tion (Brass et al., 2008; Zhou and Sharp, 1996) and in general
regulation of cellular mRNA transcription and splicing (Miller
et al., 2011). Two additional commonly changed (upregulated)
proteins in both early time points, namely GPI and SLC3A2 have
been shown to interact with HIV-1 proteins, suggesting that the
levels of host interactors are possibly manipulated early on in the
course of HIV infection.
We further investigated what key cellular functions might
be associated with the protein abundance changes of 348 DE
proteins. We used IPA to perform functional analysis using 2847
detected proteins as a reference list. The results are summarizedFig. 4. (a) Overlap of the 266 DE proteins at 4 hpi, 60 DE proteins at 8 hpi, and 22
DE proteins at 20 hpi (348 total DE proteins) with FCZ1.4, and P-valuer0.05 in at
least one time point is shown in the Venn diagram. (b) Heatmap of the 348
cumulatively DE proteins in at least one time point is plotted by hierarchical
clustering of the DE proteins based on the log2 intensity ratios of HIV-infected to
time-matched mock-infected samples at 4, 8, and 20 hpi. The directionality of
protein abundance change is denoted by red (upregulated, FCZ1.4), green
(downregulated, FCr1.4) and black (unchanged) colored bars.
Fig. 5. Top biological functions associated with DE proteins as identiﬁed by IPA at
(a) 4 hpi, (b) 8 hpi, and (c) 20 hpi. The enrichment score ( log10 transformed)
associated with each category are shown (horizontal axis) along with the number
of DE proteins on right. The DE proteins had a fold change (FC) of Z1.4 and t-test
associated P-valueo0.05 in at least one time point.
Fig. 6. Network derived from functional analysis of the DE proteins in IPA showing
connections among DE protein synthesis-related proteins (a) at 4 hpi. The majority
of members of this network belong to ribosome assembly and translation factors.
These proteins were upregulated (in red), with few exceptions such as EIF3C
which was downregulated (in green). Time-course changes in protein abundance
of these proteins at 8 hpi (b) and 20 hpi. for the network described in (a). (For
interpretation of the references to color in this ﬁgure legend, the reader is referred
to the web version of this article.)
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points and the enriched functional categories at 4 hpi, namely,
protein synthesis, cell proliferation, DNA recombination, repair
and maintenance were associated with the most DE proteins, in
contrast to the categories enriched at 8 and 20 hpi. Taken
together, this suggests that the infected T cell shows sign of brief
cell protein biogenesis and proliferation and maintenance which
then subsides with the progression of infection.
Proteins associated with protein synthesis increased in abundance
at 4 hpi
Four hours after infection marks a point in HIV-1 life cycle
when internalized virions have undergone uncoating, reverse
transcription of genomic RNA, translocation of preintegration
complexes to the nucleus and integration of viral cDNA in host
cell genome. Attendant to these processes is the cellular response
to binding and internalization of virus particles as well as changes
triggered by interactions of the internalized virus proteins with
their cellular binding partners. Consistent with this notion, we
found protein synthesis as the most enriched category (P-value
1.12E-12) with 52 DE proteins at 4 hpi, while at 20 hpi 9 DE
proteins were associated with this category (P-value 5.55E-5)
(Fig. 5c). We found only 4 DE proteins associated with protein
synthesis (ETF1, SLC7A1, RPS5, TFRC) commonly changing at
4 and 20 hpi (Suppl. Table S2). Notably, eukaryotic translationtermination factor 1 (ETF1) was strongly downregulated early
after infection, and remained still signiﬁcantly downregulated at
the 20 hpi time point, unlike most other proteins involved in
protein synthesis (discussed below). These proteins are ﬁrst
upregulated at 4 hpi, which is followed by downregulation or no
change at late time point. ETF1 participates in protein synthesis as
a polypeptide chain release factor directing termination of mRNA
translation from the stop codons, and also in nonsense-mediated
decay of prematurely terminated mRNAs. Membrane proteins
solute carrier family 7 (cationic amino acid transporter), member
1 (SLC7A1) and transferrin receptor (TFRC) were noted as sig-
niﬁcantly downregulated in both early and late time points
(SLC7A1) or up- and downregulated, respectively. Decrease of
TFRC (CD71) abundance during HIV-1 infection has been described
previously (Madrid et al., 2005) and associated with nef-induced
alteration of trafﬁcking of surface proteins involved in adaptive
immunity and HIV-1.
About 69% of the proteins (36 out of 52) involved in protein
translation at 4 hpi were ribosomal, eukaryotic translation elon-
gation, or initiation factors that showed increased abundances in
the virus-infected cells at 4 hpi (Suppl. Table S2). As summarized
in Fig. 6a, differential protein abundance was found for the
components of both ribosomal subunits. With few exceptions,
these same proteins showed a decrease or no change in abun-
dance at 8 and 20 hpi (Fig. 6b and c; for complete list of proteins,
Fig. 7. Heatmap of (a) 16 DE proteins enriched in DNA repair and recombination
functional category at 4 hpi and (b) 10 DE proteins associated with this category at
8 hpi. A single protein OTUB1 involved in DNA double-strand breakup was found
DE at both time points (4 and 8 hpi). However this protein showed different
directionality in abundance level changes at these time points. The directionality
of protein abundace change is denoted by red (upregulated, FCZ1.4), green
(downregulated, FCr1.4) and black (unchanged) colored bars. (For interpretation
of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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synthesis was down-regulated over the course of the infection as
one might expect from previous reports (Chan et al., 2009).
However, it is very surprising that protein synthesis was elevated
at 4 hpi, as judged by DE proteins. Ribosomal proteins, among
many other housekeeping (HK) proteins, are commonly regarded
as constitutively expressed in eukaryotic cells, raising a concern that
the observed effect at 4 hpi was a possible artifact introduced by
normalization. To eliminate this possibility, we examined the
expression levels of the other known HK proteins in our dataset.
We used a list of 566 human HK genes (Eisenberg and Levanon, 2003)
(http://www.compugen.co.il/supp_info/Housekeeping_genes.html),
that includes genes for 40 ribosomal proteins and 7 translation and
elongation factors. Excluding the ribosomal and eukaryotic translationinitiation and elongation proteins, 220 HK proteins were detected in
our dataset. The fold change ratios of these proteins (HIV: Mock) were
calculated for 4 hpi data. We found that 97% of HK proteins (214/220)
did not show signiﬁcant change in abundance (FCZ1.4) (Suppl.
Fig. S5). This analysis suggests that the observed increase in abun-
dance of the ribosomal and translation related proteins is not a
methodological artifact, as we would anticipate this impacting all the
housekeeping proteins.
Such abundance changes in the protein synthesis machinery
have not been previously reported in HIV-1-infected CDþT cells,
especially at such an early time point. Infection of T cells by HIV-1
has been previously associated with reduced transcript levels for
several elongation initiation factors, ribonucleoprotein complex/
ribosome assembly and protein synthesis at later (24 hpi) time
points (van’t Wout et al., 2003). Chan et al. described similar
changes in the ribosomal proteins of HIV-1 infected primary
T-cells at 8 hpi, albeit with far fewer identiﬁed proteins (Chan
et al., 2009).
The upregulation of ribosomal proteins at 4 hpi, may indicate
post-transcriptional regulation. mRNAs encoding ribosomal pro-
teins, contain 5’UTR terminal Oligopyrimidine (TOP) tracts that
regulate their translational activity (Levy et al., 1991) through
interaction with a number of RNA-binding proteins, including
RPS6 (Hagner et al., 2011). Up-regulation of RPS6 is associated
with protein synthesis and cell proliferation, during which this
ribosomal protein is activated by phosphorylation by 40S riboso-
mal protein S6 kinase (p70-S6K) (Meyuhas, 2008). p70-S6K is in
turn activated as a consequence of a variety of signal transduction
cascades such as Akt2 and mTOR but it has been also observed
that Env gp41can activate the p70-S6K subunit RBS6KB1(Barcova
et al., 1999), although this latter data was not explicitly derive
from an actual infection model. It is therefore conceivable that
HIV-1 elicits early proliferative response target cells, with many
components driven by post-transcriptional regulation.
We observed enrichment of protein synthesis functional cate-
gory also at 20 hpi, however it pertained to a different set of 9 DE
proteins, and except for a protein product of gene RSL1D1
(ribosomal protein L1 domain), abundances of these proteins were
decreased (Suppl. Fig. S6). Interestingly, RSL1D1 protein did not
change signiﬁcantly at early hours (4 and 8 hpi) of infection but
showed 1.6- fold increase at 20 hpi. This protein has been showed
to be involved in protein localization of nucleolar proteins (Meng
et al., 2006) as well as it has been identiﬁed in siRNA screen as a
dependency factors for HIV-1 infection (Brass et al., 2008).
Changes in cell proliferation and DNA repair, recombination and
maintenance
Increased abundance of proteins involved in ribosome biogen-
esis and in protein synthesis typically reﬂects a cellular state
with higher biosynthetic demand, such as in proliferating cells
(Montanaro et al., 2008). As described above, cell proliferation is
among the top functional categories (P-value 7.43E-3) at 4 hpi
with 54 DE proteins (Suppl. Table S3), of which a slight majority
was upregulated (35 vs. 24 downregulated; with a few excep-
tions, these proteins did not show signiﬁcant changes at 8 and
20 hpi). While one of the hallmarks of HIV-1 infection is cell death
by apoptosis, it is possible that the initial response to the virus
binding to the cell surface is proliferative. The crosslinking of the
HIV-1 envelope protein and CD4 and CXCR4 virus receptor and
co-receptor may trigger some aspect of TCR (T cell receptor)
signaling, providing a proliferative signal to the recipient T cells
that are not actively proliferating under physiological conditions
(Kornfeld et al., 1988; Misse et al., 1999). It is therefore con-
ceivable that interaction of the viral envelope protein with CD4
receptor primes CD4þ SUP-T1 cells for a proliferative response
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however, this response is brief and ultimately overshadowed by
viral cytotoxicity leading to apoptosis and necrosis.
Several proteins involved in DNA repair and recombination
process changed in abundance at 4 hpi (16 DE proteins, Fig. 7a)
and 8 hpi (10 DE proteins, Fig. 7b), suggesting that this category
was highly affected early during the infection (Suppl. Table S4).
The two sets of DE proteins at 4 and 8 hpi had a single protein in
common, ubiquitin thioesterase (OTUB1). This deubiquitinating
enzyme suppresses RNF168-dependent ubiquitination of the DNA
double-strand breaks by binding ubiquitin-conjugating enzyme
E2N (UBE2N) (Nakada et al., 2010). We identiﬁed OTUB1 and
UBE2N changing in opposite directions at 4 hpi, where OTUB1
was signiﬁcantly downregulated and UBE2N was upregulated.
Functionally, this would allow more chromatin ubiquitination at
double-stranded breaks, leading to more efﬁcient localization of
the genome repair machinery, suggesting there is initial attempt
of the infected cells to control the DNA damage due to infection.
However at 8 hpi, the deubiquitinating enzyme OTUB1 was
upregulated (1.4-fold), while the abundance level of UBE2N
returned to the level observed in mock-infected cells, and by
20 hpi, both proteins were unchanged compared to their levels in
the time-matched mocks. As a consequence, the initial DNA
damage response has declined, as the levels of UBE2N and other
proteins involved in DNA repair and mitosis checkpoint activation
returned to those observed in time-matched mocks (Fig. 7).
T-cell functions affected throughout the course of the infection
At the late time point (20 hpi) we found that almost 32% of the
22 DE proteins were enriched for activation-induced cell death of
T lymphocytes (P-value 2.75E-5) (Fig. 5c). Proteins involved in
T-cell activation and cell-mediated immune response (LCK, SPN,
RAC2, PARP1, HSPD1, HMGB1) were altered at 20 hpi, and some at
4 hpi (Suppl. Table S5). T-cell activation-related proteins LCK
(Lymphocyte speciﬁc protein kinase), SPN (sialophorin), and
RAC2 (ras-related C3 botulinum toxin substrate 2) were down-
regulated at 20 hpi. Down-regulation of LCK on protein level is
consistent with the previously observed transcriptional level
changes of this protein (Chang et al., 2011). SPN protein which
has been reported to participate in T-cell migration (Cannon et al.,
2011) remained down-regulated at early and later time points,
while RAC2, which is implicated in T-cell activation (Ramaswamy
et al., 2007) and proliferative response (Bustelo, 2002) was
initially up-regulated but then decreased at 20 hpi. Heat shock
protein 60 (HSPD1) has been shown to play a role in the
chemotactic migration of T cells in blood (Zanin-Zhorov et al.,
2003) as well as in binding with HIV gp41 membrane protein
(Speth et al., 1999). The later interaction of HSPD1 with the HIV
membrane protein is more relevant in our study, where the
increased levels of this protein at 4 hpi potentially help the entry
of the virus. HMGB1, a nuclear protein which is known to play a
signiﬁcant role in DNA architecture(Bonaldi et al., 2003) has also
been implicated in cell signaling(Wang et al., 1999). Overall, the
differential expression of proteins related to T-cell activation
upon HIV infection indicates that HIV-1 infection elicited protein
abundance changes that may lead to suppression of T-cell
immune function during the entire course of infection, and not
just at the later time point.
Differentially regulated host proteins with known viral–host protein
interactions
We cross-examined our list of 348 DE proteins with those
known to interact with HIV proteins by searching against previously
published HIV-human protein–protein interactions databases,such as the recently developed ‘Human Immunodeﬁciency Virus
Type 1 (HIV-1), ‘Human Protein Interaction database’ (HHPID) at
NCBI, (Fu et al., 2009; Pinney et al., 2009; Ptak et al., 2008) and the
recently published database by Jager et al. (2012). HHPID con-
tained1439 unique proteins and over 2500 unique HIV-human
protein–protein interactions (PPIs), while Ja¨ger’s database com-
prised of 242 unique proteins with 497 interactions. We found
our DE set of proteins enriched in HIV interactors with 65
(P-valuer0.015) and 26 (P-valuer0.083) matched with HHPID
and Ja¨ger’s databases, respectively, with 4 DE proteins, namely
KARS, RANBP1, PSMB6, VPRBP, overlapping between the two sets
(Table 2; marked by asterisk). Of these 4 DE proteins, levels of
KARS were down regulated from 8 hpi through 20 hpi, while the
remaining three proteins were only changed at 4 hpi. Notably, we
found that the abundance of karyopherin alpha 3 (importin alpha
4) transiently decreased at 4 hpi. The role of this protein in the
nuclear import of HIV pre-integration complex via its interaction
with incoming virion matrix protein has been reported (Bukrinsky
and Haffar, 1998), and the reduced abundance would be expected
to mitigate the extent of incorporation of viral genome. Transferrin
receptor CD71 showed a transient increase at 4 hpi, HIV Nef
protein (also present in viral particles) disrupts the endosomal
trafﬁcking of CD71 to enhance Nef-mediated viral infectivity
(Madrid et al., 2005), and the disruption of CD71 degradation in
the endosome could result in the increased abundance we
observe. It is conceivable that interactions between the viral and
cellular proteins modulate the quantity of the latter and thus
promote viral replication in infected SUP-T1 cells.Conclusions
In our study, we utilized a high-throughput quantitative
proteomic analysis to identify changes in host cell protein abun-
dance upon infection of CD4þ T cell line with HIV-1. We show
here that virus infection triggers perturbations in host proteome at
a very early stage of infection before de novo production of viral
proteins. Among the most signiﬁcantly affected cellular functions
were protein synthesis (early upregulation), followed by down-
regulation of proteins involved in cell proliferation, DNA repair
and recombination, and maintenance of T cell immune function.
These changes, some of which occur very early after infection, may
suggest novel strategies by which the HIV-1 virus manipulates
host cell machinery to its own advantage.Materials and methods
Cells, virus, and infection
All procedures involving infectious HIV-1 were carried out in
biosafety level (BSL) 2 lab with BSL 3 practices in accordance with
the University of Washington biological safety guidelines (The
University of Washington Environment Health and Safety, 2011).
The T lymphoblastic leukemia cell line SUP-T1 was obtained from
American Type Cell Culture collection (Manassas, VA; CRL-1942)
and cultured in RPMI 1640 supplemented with penicillin (100 U/
ml), streptomycin (100 mg/ml), GlutaMAX-I (Invitrogen, Carlsbad,
CA) and 10% Fetal Bovine Serum (HyClone, Logan, UT). HIV LAI
strain was obtained from NIH AIDS Research & Reference Reagent
Program (Germantown, MD) and propagated in SUP-T1 cells. Viral
titers were measured in U373-MAGI-CXCR4CEM cells obtained
through the AIDS Research and Reference Reagent Program
following a protocol by Emerman (Vodicka et al., 1997). Synchro-
nous infections of SUP-T1 cells were carried out by suspending
cells in a concentrated inoculum with a proportion of virus
Table 2
List of the T-cell DE proteins with known HIV-1 protein interactions was obtained by comparing the DE proteins from our dataset with the
two published HIV-human protein-protein interaction databases (HHPID at NCBI and Ja¨ger’s database). Four DE proteins that were found in
both databases are marked with an asterisk.
Cellular protein Gene symbol HIV protein Log2 (FC)
4 hpi
Actin, beta ACTB Tat 0.66
X-ray repair complementing defective repair in Chinese hamster cells 6 XRCC6 Tat, Vif 0.63
X-ray repair complementing defective repair in Chinese hamster cells 5 XRCC5 Tat 0.50
RAN binding protein 1n RANBP1 Vpu, Rev 0.73
Lactate dehydrogenase A LDHA Tat, Envelope gp41 0.53
Transferrin receptor (p90, CD71) TFRC Nef 0.53
moesin MSN Gag 0.50
Adapter-related protein complex 2, beta 1 subunit AP2B1 Nef 0.56
Proteasome subunit, beta type, 6n PSMB6 GP140, GP120, Tat 0.76
Karyopherin alpha 3 (importin alpha 4) KPNA3 Matrix 0.80
Vpr (HIV-1) binding proteinn VPRBP Vpr 1.10
Protein phosphatase 2, regulatory subunit B PPP2R2A Vpr 1.23
8 hpi
Importin 5 IPO5 Vpr 0.50
Glucose-6-phosphate isomerase GPI gp120 0.66
Solute carrier family 3 SLC3A2 gp160 0.76
Small nuclear ribonucleoprotein polypeptides B and B1 SNRPB Tat 0.90
Lysyl-tRNA synthetasen KARS Matrix, Gag, Capsid 0.47
HIV-1 Tat speciﬁc factor 1 HTATSF1 Tat 0.47
20 hpi
Vinculin VCL Nef 0.50
Caspase 3, apoptosis-related cysteine peptidase CASP3 Vpr 0.47
Lymphocyte-speciﬁc protein tyrosine kinase LCK Nef 0.47
Transferrin receptor (p90, CD71) TFRC Nef 1.06
Sialophorin SPN gp120 1.73
Eukaryotic translation initiation factor 4 gamma EIF4G1 Retropepsin 0.56
A.T. Navare et al. / Virology 429 (2012) 37–46 43corresponding to a multiplicity of infection (MOI) 2.5 for 1 h at
37 1C in an incubator with 5% CO2 atmosphere. After this 1 h
period of virus attachment and internalization, unattached virions
were removed by washing the cells with an excess of fresh media
and then plating the washed cells in fresh media at a density of
1106 cells/mL. Infections were performed in triplicate. The
infectious dose (MOI 2.5) was optimized to reach near 100%
of cell infectivity. Infected cells were visualized by immuno-
ﬂuorescence assay with rabbit HIV-1SF2 HIV p24 antiserum
kindly provided by BioMolecular Technologies through the AIDS
Research and Reference Reagent Program. HIV-1 mRNA relative
abundance was measured using Taqman assay with a standard
curve to ensure linearity of the assay (forward primer HXB2-Gag-
F 50-CAA GCA GCC ATG CAA ATG TT-30, reverse primer SK431-B
50-TGC TAT GTC ACT TCC CCT TGG TTC TCT-30 and probe HXB2-
gag 50-FAM AAA GAG ACC ATC AAT GAG GAA GCT GCA GAA
30-TAMRA).Protein extraction, digestion and iTRAQ labeling
For each condition, 5 million SUP-T1 cells were collected by
centrifugation at 1000 g for 5 min at 4 1C. Cell pellets were
washed twice with cold Dulbeco’s phosphate buffered saline then
snap frozen and stored at 80 1C. Cell pellets were resuspended
in 0.3 ml of urea buffer (8 M urea in 50 mM ammonium bicarbo-
nate, pH 7.8) and denatured at room temperature for 1 h with
agitation at 1000 rpm. The resulting suspensions were sonicated
in a chilled water bath cup-horn (Qsonica, Newtown, CT) at 35%
amplitude for 3 cycles (1 min pulse followed by 2 min on ice).
Residual cell debris was removed by centrifugation at 16,000 g
for 10 min at 4 1C, and the supernatant was collected. Total
protein concentration was determined with Bio-Rad Protein
Assay Dye Reagent using manufacturer’s instructions (Bio-Rad,
Hercules, CA).All steps were performed at room temperature unless other-
wise noted. Protein samples (245 mg) were reduced with 5 mM
dithiothreitol for 1 h, then alkylated with 15 mM iodoacetamide
for 30 min in the dark. Samples were diluted 8-fold with 50 mM
ammonium bicarbonate (pH 7.8), then digested with Sequencing
Grade Modiﬁed trypsin (Promega, Madison, WI) at a ratio of 1:50
(trypsin to protein) for 16 h at 37 1C. Peptides were desalted and
concentrated using Discovery C18 SPE cartridges (Supelco, Belle-
fonte, PA) as per the manufacturer’s recommendations then dried
by vacuum centrifugation and stored at 80 1C.
We checked the efﬁciency of trypsinization of ribosomal proteins
in HIV-infected and mock-infected protein extracts to rule out
the possibility that the difference in the structural stability of the
ribosomes in the HIV-infected cells might have affected the
tryptic digestion, thus resulting in apparent differences in abun-
dance. To investigate this possibility, we looked at the percen-
tages of missed cleavages in ribosomal peptides. We did not ﬁnd
any bias toward any biological condition in our study. Therefore,
we believe that difference in trypsinization as a potential source
of variability did not contribute to the observed differences in
abundance (see Results section).
iTRAQ labeling was carried out using iTRAQ Reagents 8-plex
kit (AB Sciex, Foster City, CA) as recommended in the manufac-
turer’s protocol. Fig. 1 shows a diagram of the peptide labeling
scheme used in this study. Brieﬂy, peptide pellets were resus-
pended in 3% acetonitrile and peptide concentration was deter-
mined by BCA assay (Pierce, Rockford, IL). For each sample, an
equal peptide amount (43 mg) was aliquoted then dried by
vacuum centrifugation. Peptide pellets were suspended in 0.5 M
triethylammonium bicarbonate (pH 8.5) and labeled with 1 unit
of the appropriate iTRAQ labeling reagents (113 through 119) for
2 h (Fig. 1). Additionally, we created a ‘pool’ sample by mixing
7 mg of peptides from the 18 samples (3 HIV-infected and
3 time-matched mock at 4, 8, and 20 hpi) and labeled it with an
iTRAQ label 119 (Suppl. Table S1) for use as a common reference
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normalization. Labeling reactions were then combined and the
iTRAQ multiplex sample volume was reduced by vacuum centri-
fugation. Each iTRAQ multiplex experiment was fractionated off-
line using Discovery Strong Cation Exchange (SCX) SPE cartridges
(Supelco) as per manufacturer’s recommendations with increasing
concentrations (300, 400, 500, 600, and 1000 mM KCl, in 25%
acetonitrile, 10 mM potassium phosphate monobasic, pH 3) of
potassium chloride buffer. Fractions 300 mM and, 400 mM were
combined into one fraction, and fractions 600 mM and 1 M were
combined into a second fraction before proceeding with the
desalting step. The third fraction with 500 mM KCl was not
combined with the other fractions as it had the highest amount
of peptide concentration, as determined by the BCA assay. Finally,
the three KCl fractions were desalted using Discovery C18 SPE
cartridges.
LC-MS/MS data acquisition
Online peptide separation followed by mass spectrometric
analysis was performed on a 1D-nanoLC system (nanoAcquity
UPLC system, Waters Corp.,Milford, MA, USA) coupled to a LTQ
Orbitrap Velos mass spectrometer (Thermo Fisher Scientiﬁc, CA,
USA), equipped with a high energy collision cell. Individual C-18
puriﬁed SCX fractions containing the iTRAQ labeled peptides were
injected (4 mg/5 mL injection volume) in duplicates and captured
onto a trap column packed with reverse phase beads (Symme-
trys, C18, 5 mm particle size, 100 A˚ pore size, 5 cm packing
length, 150 mm column i.d.). Peptide separation was achieved on
an analytical nano-column (Symmetrys, C18, 5 mm particle size,
100 A˚ pore size, 15 cm packing length, 75 mm column i.d.) using a
gradient from 3 to 80% of solvent B in A over 210 min (Solvent A:
100% water, 0.1% Formic acid (FA); Solvent B: 97% ACN/3% Water,
0.1% FA) at a ﬂow rate of 200 nL/min. The efﬂuent from the HPLC
column was directly electrosprayed into the mass spectrometer.
The mass spectrometer was operated in data-dependent mode
to automatically switch between MS and MS/MS acquisitions. The
Top 10 method was used in the data-dependent mode where each
full-scan MS (from m/z 300–2000) was acquired in the Orbitrap
analyzer (resolution¼60,000), followed by ﬁrst high energy colli-
sion induced dissociation (HCD) MS/MS (from m/z 100–1700) and
a subsequent low collision induced dissociation (CID) MS/MS scan
of the top 10 most intense precursor ions with a charge states
Z2. The HCD MS/MS scans were acquired using the Orbitrap
system (resolution¼30,000) at normalized collision energy of 75%
and the low-energy CID MS/MS scans were scanned in a low-
pressure ion trap with a normalized collision energy of 35%. The
ion selection threshold was set to 5000 counts for HCD, and 500
counts for CID scans. Precursor ion isolation width of 1.5 was used
for the MS/MS scans and the maximum allowed ion accumulation
times were set to 500 ms for full scans and 250 ms for HCD, and
25 ms for CID scans.
The standard mass spectrometer tune method settings were as
follows: Spray voltage, 2.1 kV; no sheath and auxiliary gas ﬂow;
heated capillary temperature, 325 1C; Automatic Gain Control
(AGC) enabled. All samples were analyzed by LC-MS/MS in
duplicates, and an equimolar (500 fmol/mL) binary peptide stan-
dard mix of angiotensin I and neurotensin (Sigma-Aldrich, St.
Louis, MO, USA) was used between the sample runs to check the
run-to-run reproducibility of the LC-MS system.
Protein identiﬁcation
Raw MS/MS data ﬁles were processed by Tagtraq (The
University of Washington’s Proteomic Resource Facility (UWPR),
2011), which merges HCD and CID MS/MS scans for each precursorion and generates merged.mgf output ﬁles for every precursor ion
detected by the mass spectrum. The merged.mgf ﬁles were
imported into the ‘Trans-Proteomic Pipeline’ (TPP) (Deutsch
et al., 2010) for protein identiﬁcation using the X!Tandem search
engine. The protein search was performed against a user deﬁned
database consisting of 35,284 human proteins (Original source:
Uniprot_Human version, released on 2011-03-08), and 123 viral
proteins containing protein sequences of HIV strains LAI, HXB2,
BRU, and IIIB (obtained from GeneBanks, accessed in October
2010) (Benson et al., 2011). The following variable modiﬁcations
were used: Oxidation of met (þ15.994915 Da), carbamidomethy-
lation of Cysteine (þ57.021464 Da), andþ304.2 Da at K due to
iTRAQ 8-plex labeling of N-termini or lysine-side chains of tryptic
peptides. All identiﬁed peptides (and corresponding proteins)
passing with error ratesr 5% and with corresponding Peptide-
Prophet (Keller et al., 2002) probabilities Z0.70 were retained. A
total of 9749 unique peptides corresponding to 2847 unique
proteins were identiﬁed across all the samples.
Protein quantitation by iTRAQ
Protein quantiﬁcation based on the iTRAQ labels was per-
formed with Libra software (Pedrioli et al., 2006) embedded in
TPP. The intensity of label 119 from the pool sample was used to
calculate the relative intensities of the other reporter ions (iTRAQ
labels) in the 8-plex. We checked the between labels intensity
variability by calculating correlation between two reporter ions of
peptides identiﬁed in all three biological replicates. A tight overall
correlation between each pair of iTRAQ ions was found (R2¼0.99)
(e.g., see correlation plot for 113 and 114 ions, Suppl. Fig. S1). The
Libra normalized log10 intensity ratios for each sample (each
label) were normalized to the median of 0 under the assumption
that the majority of proteins do not change in abundance. We
checked the data quality of the iTRAQ quantitation datasets for 4,
8, and 20 hpi, by plotting scatter plots of intensities of iTRAQ
labels for mock-infected samples as well as HIV-infected samples
at 4 hpi vs 8 hpi (113 vs 115; 114 vs 116), 4 hpi vs 20 hpi (113 vs
117; 114 vs 118) and 8 hpi vs 20 hpi (115 vs 117; 116 vs 118)
(Suppl. Fig. S2). A good overall correlation (R2¼0.98–0.99) between
different conditions at different time points suggested that the
iTRAQ data quality was comparable between the samples, and no
bias was introduced by the normalization procedure. In order to
maintain high quality data, all proteins with single peptide–
peptide based identiﬁcations were excluded from further analysis.
Two-sample unequal variance t-test was performed to derive
lists of differentially abundant proteins between infected and
mock-infected samples at each time point. To correct for multiple
hypothesis testing, we applied Benjamini–Hochberg (BH) P-value
correction. The ﬁnal list of differentially expressed (DE) proteins
corresponded to the adjusted P-valuer0.05. All computational
data processing and statistical tests were performed using custom
scripts in Perl and MATLAB, using the statistical toolbox (Math-
Works, Inc., Natick, MA).
The accuracy of identiﬁcation of 15 of the DE proteins that
were identiﬁed by X!Tandem search engine with only 2 unique
peptides were conﬁrmed by manual inspection of the tandem
mass spectra of the peptide ions assigned to these proteins. A list
of all possible fragment ions (b-ions and y-ions) of each peptide
was generated by performing in silico fragmentation of each
peptides of interest using an online ‘peptide fragmentation gen-
erator’ tool (The University of Washington Proteomics Resource,
2011). The tandem mass spectrum of the identiﬁed peptide was
then manually checked to conﬁrm the correct assignment of the
b-ions and y-ions within the mass accuracy of 70.5 Da (Da)
(Suppl. Fig. S7). The MS1 mass spectra of these peptide precursor
ion peaks were also inspected for background noise within an
A.T. Navare et al. / Virology 429 (2012) 37–46 45isolation window of 71.5m/z around the precursor ion, as
contaminant precursor ions could affect the iTRAQ quantitation.
Protein functional pathway analysis
We used DAVID (the Database for Annotation, Visualization
and Integrated Discovery, v6.7, NCBI) to determine the molecular
functions and subcellular localization of the identiﬁed 2847
total proteins. Functional and network analysis DE proteins was
performed with Ingenuity Pathway Analysis (IPA) (Ingenuitys
Systems). We used the 2847 total proteins as our reference
dataset for the IPA analysis.Acknowledgment
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